Sophiris Bio, Inc
Company Name: Sophiris Bio, Inc. Sophiris Bio Inc. is a biopharmaceutical company. The company is engaged in the development of PRX302 (topsalysin), a targeted therapy for urological diseases (in development for the treatment of the symptoms of BPH). Ticker Symbol: SPHS (NASDAQ) Company Website: www.sophirisbio.com Social Media: Sophiris Bio LinkedIn Headquarters: La Jolla, CA Publicly Traded Companies by Sector … Read more